Peer review reports
From: GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer
Original Submission | ||
---|---|---|
30 Sep 2022 | Submitted | Original manuscript |
27 Feb 2023 | Reviewed | Reviewer Report |
27 Mar 2023 | Reviewed | Reviewer Report |
18 Apr 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 2 | ||
18 Apr 2023 | Submitted | Manuscript version 2 |
20 Apr 2023 | Reviewed | Reviewer Report |
21 Apr 2023 | Reviewed | Reviewer Report |
4 May 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 3 | ||
4 May 2023 | Submitted | Manuscript version 3 |
11 May 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 4 | ||
11 May 2023 | Submitted | Manuscript version 4 |
23 May 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 5 | ||
23 May 2023 | Submitted | Manuscript version 5 |
8 Jun 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 6 | ||
8 Jun 2023 | Submitted | Manuscript version 6 |
27 Jun 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 7 | ||
27 Jun 2023 | Submitted | Manuscript version 7 |
6 Jul 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 8 | ||
6 Jul 2023 | Submitted | Manuscript version 8 |
11 Jul 2023 | Author responded | Author comments - Liang Wu |
Resubmission - Version 9 | ||
11 Jul 2023 | Submitted | Manuscript version 9 |
Publishing | ||
13 Jul 2023 | Editorially accepted | |
28 Jul 2023 | Article published | 10.1186/s12905-023-02547-1 |